BRASILIA, Brazil, Oct. 13, 2026 /PRNewswire/ — Dept, a South Korean singer-songwriter affiliated with unikorn union Inc. and Brazilian artist IVYSON affiliated with Babel Produções are joining forces for a collaboration presented in English and Portuguese. Their…
Hiteck grants Visara, a majority-owned ophthalmology subsidiary of NovaBridge Biosciences (NASDAQ: NBP), exclusive worldwide rights, excluding Greater China, to develop and commercialize HT006.2.2 Hiteck retains all rights in Greater China, where a Phase 1b study in…
No controllers, no wearables – with a library of 30 games available at launch. SHENZHEN, China, Oct. 13, 2026 /PRNewswire/ — HUUCH, an AI–driven interactive entertainment company based in China, today announced the official U.S. launch of…
New controller delivers enhanced performance, integrated safety and cybersecurity capabilities to help machine builders meet evolving operational and regulatory demands MILWAUKEE, Oct. 13, 2026 /PRNewswire/ — Rockwell Automation, Inc. (NYSE: ROK), the world’s largest company dedicated to…
SHANGHAI, Oct. 13, 2026 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" or the "Company"), a leading manufacturer of high-purity polysilicon for the global solar PV industry, today announced it will release its…
Beyond 2 Pro and ElePro® Plus awarded industry recognition as ELEHEAR continues its mission to make personalized hearing care more accessible CHICAGO, Oct. 13, 2026 /PRNewswire/ — ELEHEAR, a company specializing in AI-powered hearing solutions, has been…
CHENGDU, China, Oct. 13, 2026 /PRNewswire/ — The 2026 European Society for Medical Oncology (ESMO) Congress will be held in Madrid, Spain, from October 23 to 27. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company",…
For the first time, Orbius customers can deploy a single, fully integrated stack through the StarEDGE platform: Multi-LEO satellite connectivity paired with Armada’s modular data centers, bringing edge computing and artificial intelligence to remote operations worldwide…
Dr. Miller will lead the advancement of the company’s AI-native biologics toward first-in-human trials, with initial clinical entry targeted for 2027 He will also establish a U.S. clinical and research site to complement the company’s research…